메뉴 건너뛰기




Volumn 125, Issue 5, 2005, Pages 510-512

Coenzyme Q-10 treatment of patients with a 7445A →G mitochondrial DNA mutation stops the progression of hearing loss

Author keywords

Antioxidant; Sensorineural hearing loss

Indexed keywords

MITOCHONDRIAL DNA; UBIDECARENONE;

EID: 18744411228     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480510026232     Document Type: Conference Paper
Times cited : (17)

References (8)
  • 1
    • 0028288558 scopus 로고
    • A novel mitochondrial point mutation in a maternal pedigree with sensorineural deafness
    • Reid FM, Vernham GA, Jacobs HT. A novel mitochondrial point mutation in a maternal pedigree with sensorineural deafness. Hum Mutat 1994;3:243-7.
    • (1994) Hum Mutat , vol.3 , pp. 243-247
    • Reid, F.M.1    Vernham, G.A.2    Jacobs, H.T.3
  • 2
    • 0028847380 scopus 로고
    • Mitochondrial mutation associated with nonsyndromic deafness
    • Fischel-Ghodsian N, Prezant TR, Fournier P, et al. Mitochondrial mutation associated with nonsyndromic deafness. Am J Otolaryngol 1995;16:403-8.
    • (1995) Am J Otolaryngol , vol.16 , pp. 403-408
    • Fischel-Ghodsian, N.1    Prezant, T.R.2    Fournier, P.3
  • 3
    • 0031962646 scopus 로고    scopus 로고
    • Mitochondrial A7445G mutation in two pedigrees with palmoplantar keratoderma and deafness
    • Sevior KB, Hatamochi A, Stewart IA, et al. Mitochondrial A7445G mutation in two pedigrees with palmoplantar keratoderma and deafness. Am J Med Genet 1998;75:179-85.
    • (1998) Am J Med Genet , vol.75 , pp. 179-185
    • Sevior, K.B.1    Hatamochi, A.2    Stewart, I.A.3
  • 4
    • 1942453308 scopus 로고    scopus 로고
    • The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants
    • Mattiazzi M, Vijayvergiya C, Gajewski CD, et al. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum Mol Genet 2004;13:869-79.
    • (2004) Hum Mol Genet , vol.13 , pp. 869-879
    • Mattiazzi, M.1    Vijayvergiya, C.2    Gajewski, C.D.3
  • 5
    • 0034054301 scopus 로고    scopus 로고
    • Prevalence of mitochondrial gene mutations among hearing impaired patients
    • Usami S, Abe S, Akita J, et al. Prevalence of mitochondrial gene mutations among hearing impaired patients. J Med Genet 2000;37:38-40.
    • (2000) J Med Genet , vol.37 , pp. 38-40
    • Usami, S.1    Abe, S.2    Akita, J.3
  • 6
    • 0025673969 scopus 로고
    • Ubidecarenone in the treatment of mitochondrial myopathies: A multicenter double-blind trial
    • Bresolin N, Doriguzzi C, Ponzetto C, et al. Ubidecarenone in the treatment of mitochondrial myopathies: a multicenter double-blind trial. J Neurol Sci 1990;100:70-8.
    • (1990) J Neurol Sci , vol.100 , pp. 70-78
    • Bresolin, N.1    Doriguzzi, C.2    Ponzetto, C.3
  • 7
    • 0030693171 scopus 로고    scopus 로고
    • Mitochondrial encephalopathy with 15915 mutation: Clinical report
    • Seki A, Nishino I, Goto Y, et al. Mitochondrial encephalopathy with 15915 mutation: clinical report. Pediatr Neurol 1997;17:161-4.
    • (1997) Pediatr Neurol , vol.17 , pp. 161-164
    • Seki, A.1    Nishino, I.2    Goto, Y.3
  • 8
    • 0031596402 scopus 로고    scopus 로고
    • The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation
    • Suzuki S, Hinokio Y, Ohtomo M, et al. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia 1998;41:584-8.
    • (1998) Diabetologia , vol.41 , pp. 584-588
    • Suzuki, S.1    Hinokio, Y.2    Ohtomo, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.